Pharmaceutical

Home » Pharmaceutical

Juniper Pharma Services Continues its Strategic Capital Investment in Oral Solid Dose Services

Claire Madden-Smith, SVP at Juniper Pharma Services Juniper Pharma Services (JPS), a contract development and manufacturing organisation (CDMO) specialising in the development of challenging small molecules, is continuing its strategic investment in oral solid dose manufacturing with a $1.7 million purchase of three additional pieces of processing equipment. This investment enhances JPS’ commitment [...]

Orion Contract Manufacturing Enters Supply Agreement with Peptonic Medical

Global contract manufacturing organisation, Orion Contract Manufacturing, has signed a commercial supply agreement with Peptonic Medical for the manufacture and packaging of its patented product, VagiVital. The over-the-counter (OTC) product is used to treat vaginal atrophy and dryness and is due to launch later this year. Following the successful transfer of the product’s manufacturing technology, [...]

Nightingale Health and UK Biobank to Analyse Half a Million Blood Samples to Facilitate Global Medical Research

Nightingale Health, the Finnish innovator of an internationally recognised blood biomarker technology for studying chronic diseases, will analyse the biomarker profiles of 500,000 blood samples from UK Biobank. Nightingale’s biomarker profiling technology will be used to analyse UK Biobank blood samples by measuring metabolic biomarkers that recent studies have found are predictive of future risk for heart [...]

Juniper Pharma Services Expands Laboratory Facilities to Meet Growing Demand

Juniper Pharma Services (JPS), a contract development and manufacturing organisation (CDMO) specialising in the development of challenging small molecules, has announced a significant expansion to its UK-based drug development and clinical trial manufacturing facilities. The extension provides four additional process development laboratories at its Nottingham site, improving the output and efficiency of its development and [...]

EMA Approval for Trazimera Marks Another Win for the Trastuzumab Biosimilars Market

Pfizer’s breast cancer drug Trazimera has moved a step closer to joining Celltrion’s Herzuma, Amgen’s Kanjinti, and Merck Sharp & Dohme’s Ontruzant in the race to seize EU market share from Roche’s blockbuster Herceptin, says GlobalData, a leading data and analytics company. In May 2018, the European Medicines Agency (EMA) Committee for Medicinal Products for [...]

Full Unblinded Dataset Required to Understand NW Bio Glioblastoma Multiforme Vaccine Survival Benefit

Despite the highly promising interim blinded survival data from US-based Northwest Biotherapeutics (NW Bio), for the Phase III clinical trial of its personalized autologous dendritic cell vaccine DCVax-L in newly diagnosed glioblastoma multiforme (GBM) patients, a full unblinded dataset is required to truly understand the vaccine’s survival benefit, says leading data and analytics company GlobalData. [...]

Orion Contract Manufacturing Enters Supply Agreement with Peptonic Medical

Global contract manufacturing organisation, Orion Contract Manufacturing, has signed a commercial supply agreement with Peptonic Medical for the manufacture and packaging of its patented product, VagiVital. The over-the-counter (OTC) product is used to treat vaginal atrophy and dryness and is due to launch later this year. Following the successful transfer of the product’s manufacturing technology, [...]

FDA Approval of Low Dose RA Drug Olumiant, Gives Eli Lilly and Incyte Edge in Immediate Future

The approval of Olumiant (baricitinib) 2 mg tablets as a once-daily oral medication for the treatment of adults with moderately-to-severely active rheumatoid arthritis (RA) by the FDA, will give global healthcare leader Eli Lilly and Delaware-based biopharma firm Incyte Corp. a head start over competitors in the RA market, says leading data and analytics company [...]

Collaboration Facilitates Continuous Manufacturing: Working Together to Make a Difference

During the recent ACHEMA trade show, which took place in Frankfurt, Germany (11–15 June), GEA hosted a joint press conference with other key suppliers to the pharmaceutical sector to highlight a number of industry collaborations that are helping to facilitate the uptake of continuous manufacturing (CM) technology in the drug production sector.  Commenting on the [...]

Record Growth at Sterling Pharma Solutions

A UK-based contract development and manufacturing organisation (CDMO) has more than doubled its sales since its formation in 2016 as demand for its hazardous chemistry capabilities and active pharmaceutical ingredient (API) services grows. Sterling Pharma Solutions, which launched as an independent CDMO following a management buyout (MBO) of the Shasun Pharma Solutions Dudley site in [...]